A cross-specialty survey to assess the application of risk stratified surgery for differentiated thyroid cancer in the UK.

INTRODUCTION This study describes variability of treatment for differentiated thyroid cancer among thyroid surgeons, in the context of changing patterns of thyroid surgery in the UK. METHODS Hospital Episodes Statistics on thyroid operations between 1997 and 2012 were obtained for England. A survey comprising six scenarios of varying 'risk' was developed. Patient/tumour information was provided, with five risk stratified or non-risk stratified treatment options. The survey was distributed to UK surgical associations. Respondent demographics were categorised and responses analysed by assigned risk stratified preference. RESULTS From 1997 to 2012, the Hospital Episode Statistics data indicated there was a 55% increase in the annual number of thyroidectomies with a fivefold increase in otolaryngology procedures and a tripling of cancer operations. Of the surgical association members surveyed, 264 respondents reported a thyroid surgery practice. Management varied across and within the six scenarios, and was not related consistently to the level of risk. Associations were demonstrated between overall risk stratified preference and higher volume practice (>25 thyroidectomies per year) (p=0.011), fewer years of consultant practice (p=0.017) and multidisciplinary team participation (p=0.037). Logistic regression revealed fewer years of consultant practice (odds ratio [OR]: 0.96/year in practice, 95% confidence interval [CI]: 0.922-0.997, p=0.036) and caseload of >25/year (OR 1.92, 95% CI: 1.044-3.522, p=0.036) as independent predictors of risk stratified preference. CONCLUSIONS There is a substantial contribution to thyroid surgery in the UK by otolaryngology surgeons. Adjusting management according to established case-based risk stratification is not widely applied. Higher caseload was associated with a preference for management tailored to individual risk.

[1]  Victor M Montori,et al.  Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours , 2013, BMJ.

[2]  S. Roman,et al.  Can Minimally Invasive Follicular Thyroid Cancer be Approached as a Benign Lesion? , 2013, Annals of Surgical Oncology.

[3]  R. Valcavi,et al.  Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. , 2012, Thyroid : official journal of the American Thyroid Association.

[4]  P. Hallgrimsson,et al.  Risk Factors for Medically Treated Hypocalcemia after Surgery for Graves’ Disease: A Swedish Multicenter Study of 1,157 Patients , 2012, World Journal of Surgery.

[5]  N. Voirin,et al.  Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study , 2012, BMJ : British Medical Journal.

[6]  Jonathan R. Clark,et al.  Central Compartment Dissection in Thyroid Papillary Carcinoma , 2011, Annals of surgery.

[7]  K. J. Lim,et al.  Locally advanced thyroid cancer: can CT help in prediction of extrathyroidal invasion to adjacent structures? , 2010, AJR. American journal of roentgenology.

[8]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[9]  A. Schott,et al.  Hospital volume influences the choice of operation for thyroid cancer , 2009, The British journal of surgery.

[10]  Amy Y. Chen,et al.  Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005 , 2009, Cancer.

[11]  M. Vaiman,et al.  Complications in primary and completed thyroidectomy , 2010, Surgery Today.

[12]  C. Ko,et al.  Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. , 2007, Surgery.

[13]  Y. Anzai,et al.  Magnetic Resonance Imaging of Thyroid Cancer , 2007, Topics in magnetic resonance imaging : TMRI.

[14]  J. Lefèvre,et al.  Reoperative surgery for thyroid disease , 2007, Langenbeck's Archives of Surgery.

[15]  A. Shaha.  TNM Classification of Thyroid Carcinoma , 2007, World journal of surgery.

[16]  A. Pierro,et al.  A systematic review of the impact of volume of surgery and specialization on patient outcome , 2007, The British journal of surgery.

[17]  MD S. CROSS,et al.  Selective surgery and adjuvant therapy based on risk classifications of well‐differentiated thyroid cancer , 2006, Journal of surgical oncology.

[18]  J. Shah,et al.  Low-risk differentiated thyroid cancer: The need for selective treatment , 1997, Annals of Surgical Oncology.

[19]  M. Gonen,et al.  Long-Term Survival Is Superior After Resection for Cancer in High-Volume Centers , 2005, Annals of surgery.

[20]  David D. Smith,et al.  The Implication of Lymph Node Metastasis on Survival in Patients with Well-Differentiated Thyroid Cancer , 2005, The American surgeon.

[21]  Johannes Haerting,et al.  Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. , 2004, Surgery.

[22]  R. Weber,et al.  Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. , 2004, Archives of otolaryngology--head & neck surgery.

[23]  T. Ebeling,et al.  Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. , 2004, Endocrine-related cancer.

[24]  Charles Vincent,et al.  Systems Approaches to Surgical Quality and Safety: From Concept to Measurement , 2004, Annals of surgery.

[25]  A. Shaha.  Implications of Prognostic Factors and Risk Groups in the Management of Differentiated Thyroid Cancer , 2004, The Laryngoscope.

[26]  Robert E Harbaugh,et al.  Surgeon Volume and Operative Mortality in the United States. , 2004, Neurosurgery.

[27]  J. Ramsden,et al.  Who performs thyroid surgery: a review of current otolaryngological practice. , 2002, Clinical otolaryngology and allied sciences.

[28]  W. Mendenhall,et al.  Follicular thyroid carcinoma , 2002, Cancer.

[29]  H. Johansson,et al.  The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer , 2002, The British journal of surgery.

[30]  A. Oberg,et al.  Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients , 2002, World Journal of Surgery.

[31]  M. Urist,et al.  Extent of surgery for intermediate-risk well-differentiated thyroid cancer. , 2000, American journal of surgery.

[32]  N. Powe,et al.  The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. , 1998, Annals of surgery.

[33]  Q. Duh,et al.  Diagnosis, treatment, and outcome of follicular thyroid carcinoma , 1993, Cancer.

[34]  E. Bergstralh,et al.  Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. , 1991, Mayo Clinic proceedings.

[35]  R K Shukla,et al.  Comparison of Subjective versus Data Base Approaches for Improving Efficiency of Operating Room Scheduling , 1990, Health services management research.

[36]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.